Comparison of docetaxel/doxorubicin/cyclophosphamide (tac) versus vinorelbine/capecitabine (nx) in patients non-responding to 2 cycles of neoadjuvant Tac chemotherapy - first results of the phase Iii Gepartrio-study by the German Breast Group